TEGO SCIENCE, leveraging world-class cell culture technology, focuses on the development and production of cell therapies as its main business. It provides consulting, contract manufacturing, and quality control services for cell therapy development. The company utilizes 3D skin models for new drug discovery and efficacy validation, and is expanding its technology to artificial skin production. Cell therapies, the company's primary focus, are gaining attention as a differentiated alternative to conventional medicines by offering fundamental treatment solutions for diseases.

Cutigen Research Institute has been successfully developing and commercializing Holoderm®, Kaloderm®, Neoderm® and Rosmir®. Cutigen's fundamental strength lies in its world-class capabilities in (any types of) cell culture. Based on this strong foundation, we are developing pipelines in regenerative medicine, stem cell and alternative testing spaces.

Public

Biotech